Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)

NCT01857115 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

63

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]